硅寶科技(300019.SZ):擬投資1.5億元建設有機硅先進材料研發及產業化項目
格隆匯1月2日丨硅寶科技(300019.SZ)公佈,公司2023年12月14日召開第六屆董事會第十三次會議,審議通過《關於對外投資的議案》,同意公司在上海市投資1.5億元設立硅寶科技(上海)有限公司(具體以主管機關最終登記為準)建設有機硅先進材料研發及產業化項目。
公司今日與上海市閔行區顓橋鎮人民政府簽訂《投資協議書》,公司決定在上海市閔行區顓橋鎮元江片區購置約16畝工業用地,投資15,000萬元用於建設有機硅先進材料研究及產業化開發項目,項目包括硅寶上海研發中心、硅寶上海營銷中心、5000噸/年電子及光學封裝材料生產線等。總投資15,000萬元,其中固定資產投資不低於8000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.